Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ASRT | US
0.02
1.79%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
1.14
1.11
1.14
1.09
Assertio Holdings Inc. a commercial pharmaceutical company provides medicines in the areas of neurology rheumatology and pain and inflammation. Its pharmaceutical products include INDOCIN an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain nausea photophobia and phonophobia; Zipsor a NSAID for relief of mild to moderate pain in adults; SPRIX a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe active rheumatoid arthritis and active polyarticular juvenile idiopathic arthritis as well as treat adult with severe recalcitrant and disabling psoriasis. The company was formerly known as Assertio Therapeutics Inc. and changed its name to Assertio Holdings Inc. in May 2020. Assertio Holdings Inc. was incorporated in 1995 and is headquartered in Lake Forest Illinois.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
47.6%1 month
61.0%3 months
72.1%6 months
81.3%-
13.11
0.85
0.31
0.15
4.03
0.48
1.31
11.21M
108.68M
108.68M
-
-17.73
-18.80
-24.10
-178.62
11.71
6.61
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.24
Range1M
0.29
Range3M
0.76
Rel. volume
0.91
Price X volume
486.84K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.42 | 117.01M | -4.70% | n/a | 8.14% |
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.7699 | 112.70M | 2.15% | n/a | 36.36% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.8874 | 110.64M | 0.40% | n/a | -148.05% |
OptiNose Inc | OPTN | Drug Manufacturers-Specialty & Generic | 0.7107 | 107.16M | 5.95% | n/a | -294.40% |
Relmada Therapeutics Inc | RLMD | Drug Manufacturers-Specialty & Generic | 3.48 | 105.01M | 2.35% | n/a | 0.00% |
Benitec Biopharma Limited | BNTC | Drug Manufacturers-Specialty & Generic | 9.48 | 95.62M | -7.06% | n/a | 0.00% |
INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 1.87 | 85.58M | 2.75% | n/a | 41.98% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.44 | 54.51M | 0.70% | n/a | 25.73% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.1014 | 42.58M | 4.54% | n/a | 0.00% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.24 | 38.49M | -7.46% | n/a | 318.92% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.64 | 83.40M | -1.93% | n/a | 58.43% |
Culp Inc | CULP | Textile Manufacturing | 5.95 | 74.32M | -2.30% | n/a | 11.29% |
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6199 | 5.90M | 6.82% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.33 | 5.20M | 0.03% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3899 | 3.55M | -0.01% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4859 | 2.44M | -9.19% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 913.02K | -1.96% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 4.03 | 17.21 | Cheaper |
Ent. to Revenue | 0.48 | 334.38 | Cheaper |
PE Ratio | - | 26.92 | - |
Price to Book | 0.85 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 72.11 | 68.34 | Par |
Debt to Equity | 0.31 | -1.00 | Expensive |
Debt to Assets | 0.15 | 0.48 | Cheaper |
Market Cap | 108.68M | 5.31B | Emerging |